Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: Cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined

Journal of Affective Disorders

Volumn 150, Issue 2, 2013, Pages 313-319

  Van Apeldoorn, Franske J ^a   Van Hout, Wiljo J P J ^b   Timmerman, Marieke E ^b   Mersch, Peter Paul A ^b   Den Boer, Johan A ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Agoraphobia; Cognitivebehavioraltherapy; Drug treatment; Panic attacks; Panic disorder; Process study; Randomized controlledtrials; Rate ofimprovement

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AGORAPHOBIA; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

AGORAPHOBIA; COGNITIVE BEHAVIORAL THERAPY; DRUG TREATMENT; PANIC ATTACKS; PANIC DISORDER; PROCESS STUDY; RANDOMIZED CONTROLLED TRIALS; RATE OF IMPROVEMENT;

ADULT; AGED; AGORAPHOBIA; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84882855693     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.04.012     Document Type: Article

References (28)

1. A. Bakker, R. Van Dyck, P. Spinhoven, and A.J.L.M. Van Balkom "Paroxetine, Clomipramine, and Cognitive Therapy in the treatment of Panic Disorder" Journal of Clinical Psychiatry 60 1999 831 838
2. B. Bandelow, J. Zohar, E. Hollander, S. Kasper, and H.J. Möller World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision The World Journal of Biological Psychiatry 9 4 2008 248 312
3. D.H. Barlow, J.M. Gorman, M.K. Shear, and S.W. Woods Cognitive-behavioral therapy, imipramine, or their combination for panic disorder Journal of the American Medical Association 283 19 2000 2529 2536
4. D.W. Black, R. Wesner, W. Bowers, and J. Gabel A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder Archives of General Psychiatry 50 1993 44 50
5. M.E. Bouton A learning theory perspective on lapse, relapse, and the maintenance of behavior change Health Pyschology 19 1 2000 57 63
6. D.M. Clark A cognitive approach to panic Behaviour Research and Therapy 24 4 1986 461 470
7. D.M. Clark, P.M. Salkovskis, A. Hackmann, H. Middleton, P. Anastasiades, and M. Gelder A Comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder British Journal of Psychiatry 164 1994 759 769
8. M.G. Craske, and D.H. Barlow Panic disorder and agoraphobia D.H. Barlow, Clinical Handbook of Psychological Disorders 1993 Guilford New York 1 47
9. M.G. Craske, K. Kircanski, M. Zelikowsky, J.L. Mystkowski, N. Chowdhury, and A. Baker "Optimizing inhibitory learning during exposure therapy" Behaviour Research and Therapy 46 2008 5 27
10. E. de Beurs, A. Lange, and R. Van Dyck Self-monitoring of panic attacks and retrospective estimates of panic: discordant findings Behaviour Research and Therapy 30 4 1992 411 413
11. T.A. Furukawa, N. Watanabe, and R. Churchill Psychotherapy plus antidepressant for panic disorder with or without agoraphobia British Journal of Psychiatry 188 4 2006 305 312
12. J.M. Gorman, J.M. Kent, G.M. Sullivan, and J.D. Coplan Neuroanatomical hypothesis of panic disorder, revised American Journal of Psychiatry 157 4 2000 493 505
13. B.F. Grant, D.S. Hasin, F.S. Stinson, D.A. Dawson, R.B. Goldstein, S. Smith, B. Huang, and T.D. Saha The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the national epidemiologic survey on alcohol and related conditions Journal of Clinical Psychiatry 67 2006 363 374
14. D.S. Moskowitz, and G. Sadikaj Event-contingent recording M.R. Mehl, T.S. Conner, Handbook of Research Methods for Studying Daily Life 2011 Guilford New York 160 175
15. Multilevel Models Project, 1995. MLN Command Reference. University of London, London.
16. P.T. Ninan, and B.W. Dunlop Neurobiology and etiology of panic disorder Journal of Clinical Psychiatry 66 Suppl. 4 2005 3 7
17. M.W. Otto, J.A.J. Smits, and H.E. Reese Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis Clinical psychology: Science and Practice 12 1 2005 72 86
18. S.J. Penava, M.W. Otto, K.M. Maki, and M.H. Pollack Rate of improvement during cognitive-behavioral group treatment for panic disorder Behaviour Research and Therapy 36 1998 665 673
19. A. Polman, T.K. Bouman, P.L. Van Geert, and J.A. Den Boer Dysfunctional beliefs in the process of change of cognitive treatment in obsessive compulsive checkers Clinical Psychology and Psychotherapy 18 3 2011 256 272
20. B. Roshanaei-Moghaddam, M.C. Pauly, D.C. Atkins, S.A. Baldwin, M.B. Stein, and P. Roy-Byrne Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Depression and Anxiety 28 2011 560 567
21. D.M. Sharp, K.G. Power, R.J. Simpson, V. Swanson, E. Moodie, J.A. Anstee, and J.J. Ashford Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia Journal of Anxiety Disorders 10 4 1996 219 242
22. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueata, R. Baker, and G.C. Dunbar The mini-international neuropsychiatric interview (m.i.n.i.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 Journal of Clinical Psychiatry 59 20 1998 22 33
23. T.A.B. Snijders, and R.J. Bosker Multilevel analysis 2000 Sage London
24. M.A. Stanley, J.G. Beck, P.M. Averill, L.E. Baldwin, E.A.I. Deagle, and J.G. Stadler Patterns of change during cognitive behavioral treatment for panic disorder Journal of Nervous and Mental Disease 184 9 1996 567 572
25. F.J. Van Apeldoorn, M.E. Timmerman, P.P.A. Mersch, W.J.P.J. Van Hout, S. Visser, R. Van Dyck, and J.A. den Boer A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up Journal of Clinical Psychiatry 71 5 2010 574 586
26. F.J. Van Apeldoorn, W.J.P.J. Van Hout, P.P.A. Mersch, M. Huisman, B.R. Slaap, W.I. Hale, S. Visser, R. Van Dyck, and J.A. den Boer Is a combined therapy more effective than either CBT or SSRI alone? results of a multicenter trial on panic disorder with or without agoraphobia Acta Psychiatrica Scandinavica 117 4 2008 260 270
27. A.J. Van Balkom, R. Van Dyck, H.J.G.M. Van Megen, L. Timmerman, I.M. Van Vliet, H.G.M. Westenberg, and J.C. Witte "Richtlijn farmacotherapie angststoornissen" A.J. Van Balkom, R. Van Dyck, H.J.G.M. Van Megen, Richtlijn farmacotherapie angststoornissen (Eds.) 1998 Dries van Ingen, Uitgeverij Boom Amsterdam 7 37
28. G. Verbeke, and G. Molenberghs Linear Mixed Models for Longitudinal Data 2000 Springer New York